AGREF (Orpheus Uranium) YoY EBITDA Growth: 33.33% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AGREF Orpheus Uranium Ltd AGREF
22 GF Score
Price $0.08
! 1 Warning Sign
View Full Analysis

What is Orpheus Uranium YoY EBITDA Growth?

Orpheus Uranium AGREF 22 YoY EBITDA Growth is 33.33% as of Dec. 2025. GuruFocus rates AGREF with a GF Score™ of 22/100. The stock has 1 warning sign investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Orpheus Uranium's YoY EBITDA Growth for the quarter that ended in Dec. 2025 was 33.33%.

Orpheus Uranium's EBITDA per Share for the six months ended in Dec. 2025 was $-0.00.

Orpheus Uranium YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Orpheus Uranium's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orpheus Uranium YoY EBITDA Growth Chart

Orpheus Uranium Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -34.55 -83.78 72.79 72.97 20.00

Orpheus Uranium Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 61.54 78.26 40.00 0.00 33.33
AGREF
22GF Score
Orpheus Uranium Ltd AGREF
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Orpheus Uranium YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Orpheus Uranium's YoY EBITDA Growth for the fiscal year that ended in Jun. 2025 is calculated as:

YoY EBITDA Growth (A: Jun. 2025 )
=(EBITDA per Share (A: Jun. 2025 )-EBITDA per Share (A: Jun. 2024 ))/ | EBITDA per Share (A: Jun. 2024 ) |
=(-0.008--0.01)/ | -0.01 |
=20.00 %

Orpheus Uranium's YoY EBITDA Growth for the quarter that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (Q: Dec. 2025 )
=(EBITDA per Share (Q: Dec. 2025 )-EBITDA per Share (Q: Dec. 2024 )) / | EBITDA per Share (Q: Dec. 2024 )) |
=(-0.002--0.003)/ | -0.003 |
=33.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 33.33% mean?
Orpheus Uranium (AGREF) has a YoY EBITDA Growth of 33.33% as of Dec. 2025. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Orpheus Uranium and its competitors.
Is Orpheus Uranium's YoY EBITDA Growth too high?
Orpheus Uranium's current YoY EBITDA Growth is 33.33%. Overall, Orpheus Uranium has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Orpheus Uranium's YoY EBITDA Growth compare to competitors?
Orpheus Uranium's YoY EBITDA Growth of 33.33% can be compared against companies in the Metals & Mining industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Metals & Mining company?
A good YoY EBITDA Growth depends on the Metals & Mining industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Orpheus Uranium and its competitors. Orpheus Uranium's current YoY EBITDA Growth is 33.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orpheus Uranium stock overvalued right now?
Orpheus Uranium (AGREF) has a current YoY EBITDA Growth of 33.33%. The current YoY EBITDA Growth is 33.33%. Orpheus Uranium's overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Orpheus Uranium (AGREF), the current YoY EBITDA Growth is 33.33% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Orpheus Uranium Business Description

Other Exchanges ORP:Australia
Address 79 King William Road, Unley, SA, AUS, 5061
Orpheus Uranium Ltd is an uranium exploration and development company focused on the uranium-friendly jurisdictions of South Australia and the Northern Territory in Australia. Company projects include Frome Project, Radium Hill South Project, Woolshed Project, Mundaerno Project, Marree Project, Mount Douglas Project, IOCG Projects and Other Projects.
22GF Score

Get the complete analysis for AGREF

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price